ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,052.98
0.69%
US Tech 100
17,018.80
0.94%
다우존스 지수
38,155.74
0.67%
Bitcoin
59,217.35
1.68%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Denali Therapeutics Inc (DNLI)

  7. Denali Therapeutics Inc (DNLI) 뉴스

DNLI Denali Therapeutics Inc

16.57
0.41 (2.54%)
최종 업데이트: 02:46:15
15분 지연
기업명 주식 심볼 시장 주식 타입
Denali Therapeutics Inc DNLI 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
Upgrade Icon
0.41 2.54% 16.57 02:46:15
개장가 저가 고가 종가 전일 종가
16.41 15.92 16.66 16.16
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
01/05/202421:00GLOBEDenali Therapeutics Announces Completion of Enrollment for..
02/03/202406:51EDGAR2Form D - Notice of Exempt Offering of Securities
27/02/202422:07EDGAR2Form 8-K - Current report
27/02/202422:05GLOBEDenali Therapeutics Reports Fourth Quarter and Full Year..
27/02/202422:03EDGAR2Form 8-K - Current report
27/02/202422:00GLOBEDenali Therapeutics Announces $500 million Private Placement..
16/02/202422:02EDGAR2Form 8-K - Current report
16/02/202411:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/02/202411:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/02/202411:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/02/202406:59EDGAR2Form 144 - Report of proposed sale of securities
15/02/202406:43EDGAR2Form 144 - Report of proposed sale of securities
14/02/202410:19EDGAR2Form 144 - Report of proposed sale of securities
14/02/202410:18EDGAR2Form 144 - Report of proposed sale of securities
14/02/202410:17EDGAR2Form 144 - Report of proposed sale of securities
13/02/202406:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/02/202422:00GLOBEDenali Therapeutics Announces New Data and Expansion of Its..
01/02/202422:00GLOBEDenali Therapeutics Announces Presentations on Its..
13/01/202410:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/01/202407:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/01/202406:09EDGAR2Form 144 - Report of proposed sale of securities
10/01/202409:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/01/202409:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/01/202409:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/01/202409:20EDGAR2Form 144 - Report of proposed sale of securities
08/01/202422:06EDGAR2Form 8-K - Current report
08/01/202422:00GLOBEDenali Therapeutics Announces Key Anticipated 2024..
06/01/202410:25EDGAR2Form 144 - Report of proposed sale of securities
06/01/202407:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/01/202407:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/01/202407:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202309:01PRNUSFlagship Pioneering Marks Official Opening of UK Hub with..
21/11/202320:00PRNUSFlagship Pioneering Unveils Quotient Therapeutics to Create..
08/11/202306:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202306:04EDGAR2Form 8-K - Current report
08/11/202306:01GLOBEDenali Therapeutics Reports Third Quarter 2023 Financial..
01/11/202323:30PRNUSFlagship Pioneering Launches Pioneering Intelligence
11/09/202319:30PRNUSFlagship Pioneering Announces Appointment of Amanda Kay as..
30/08/202321:30GLOBEDenali Therapeutics Announces New Interim Data from Phase..
29/08/202322:00PRNUSInvaio achieves first registration for citrus greening..
26/08/202306:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/08/202306:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/08/202305:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/08/202305:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/08/202305:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/08/202305:07EDGAR2Form 144 - Report of proposed sale of securities
24/08/202305:06EDGAR2Form 144 - Report of proposed sale of securities
22/08/202305:06EDGAR2Form 8-K - Current report
22/08/202303:47EDGAR2Form 144 - Report of proposed sale of securities
22/08/202303:45EDGAR2Form 144 - Report of proposed sale of securities

최근 히스토리

NASDAQ
DNLI
Denali Therapeutics
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유